Development and validation of an antibody-dependent cell-mediated cytotoxicity-reporter gene assay
Open Access
- 1 May 2012
- journal article
- research article
- Published by Informa UK Limited in mAbs
- Vol. 4 (3), 310-318
- https://doi.org/10.4161/mabs.19873
Abstract
Humanized monoclonal antibodies (mAbs) are the fastest growing class of biological therapeutics that are being developed for various medical indications, and more than 30 mAbs are already approved and in the market place. Antibody-dependent cell-mediated cytotoxicity (ADCC) is an important biological function attributed to the mechanism of action of several therapeutic antibodies, particularly oncology targeting mAbs. The ADCC assay is a complicated and highly variable assay. Thus, the use of an ADCC assay as a lot release test or a stability test for clinical trial batches of mAbs has been a substantial challenge to install in quality control laboratories. We describe here the development and validation of an alternate approach, an ADCC-reporter gene assay that is based on the key attributes of the PBMC-based ADCC assay. We tested the biological relevance of this assay using an anti-CD20 based model and demonstrated that this ADCC-reporter assay correlated well with standard ADCC assays when induced with the drugable human isotypes [IgG1, IgG2, IgG4, IgG4S > P (S228P) and IgG4PAA (S228P, F234A, L235A)] and with IgG1 isotype variants with varying amounts of fucosylation. This data demonstrates that the ADCC-reporter gene assay has performance characteristics (accuracy, precision and robustness) to be used not only as a potency assay for lot release and stability testing for antibody therapeutics, but also as a key assay for the characterization and process development of therapeutic molecules.Keywords
This publication has 55 references indexed in Scilit:
- Advances in the assessment and control of the effector functions of therapeutic antibodiesNature Reviews Drug Discovery, 2011
- Determination of Fab−Hinge Disulfide Connectivity in Structural Isoforms of a Recombinant Human Immunoglobulin G2 AntibodyAnalytical Chemistry, 2009
- Defucosylated Anti-CCR4 Monoclonal Antibody Exerts Potent ADCC against Primary ATLL Cells Mediated by Autologous Human Immune Cells in NOD/Shi-scid, IL-2Rγnull Mice In VivoPublished by The American Association of Immunologists ,2009
- The calcium/NFAT pathway: role in development and function of regulatory T cellsMicrobes and Infection, 2009
- Human IgG2 Antibody Disulfide Rearrangement in VivoJournal of Biological Chemistry, 2008
- Structural and Functional Characterization of Disulfide Isoforms of the Human IgG2 SubclassJournal of Biological Chemistry, 2008
- Human IgG2 Antibodies Display Disulfide-mediated Structural IsoformsJournal of Biological Chemistry, 2008
- Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximabBlood, 2006
- Production of recombinant protein therapeutics in cultivated mammalian cellsNature Biotechnology, 2004
- Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.The Journal of Experimental Medicine, 1987